Kevin Hershberger

President & Chief Executive Officer


Kevin joined Lumicell as Chief Financial Officer in 2018 and currently serves as President and CEO. In this role, he leads an experienced team dedicated to changing the way cancer surgery is performed today. He brings over 25 years of global executive management experience in a variety of life science products and manufacturing companies with an extensive range of expertise and leadership responsibilities. Prior to Lumicell, Kevin served as Chief Financial Officer of ReWalk Robotics, where he built the company’s finance function and launched a partnership with Harvard University’s Wyss Institute encompassing a broad licensing and collaboration agreement to develop a Softsuit Exoskeleton. He has also served as Vice President of Finance, Controller and Chief Accounting Officer at NxStage Medical, as well as in a variety of finance leadership roles at Boston Scientific. He holds a Bachelor of Science in accounting from West Virginia University.